These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15279125)

  • 1. Evolving use of buprenorphine in the treatment of addiction.
    Martin J
    J Psychoactive Drugs; 2004 May; Suppl 2():129-37. PubMed ID: 15279125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine Maintenance vs. Placebo for Opioid Dependence.
    Raleigh MF
    Am Fam Physician; 2017 Mar; 95(5):Online. PubMed ID: 28290640
    [No Abstract]   [Full Text] [Related]  

  • 3. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing opioid addiction with buprenorphine.
    Donaher PA; Welsh C
    Am Fam Physician; 2006 May; 73(9):1573-8. PubMed ID: 16719249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian developments. Buprenorphine now approved for the treatment of opiate addiction.
    Garmaise D
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):20, 22. PubMed ID: 16365961
    [No Abstract]   [Full Text] [Related]  

  • 7. Buprenorphine in the treatment of opioid dependence.
    Davids E; Gastpar M
    Eur Neuropsychopharmacol; 2004 May; 14(3):209-16. PubMed ID: 15056480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
    Shulman M; Wai JM; Nunes EV
    CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.
    Resnick RB
    Ann Intern Med; 2003 Feb; 138(4):360. PubMed ID: 12585846
    [No Abstract]   [Full Text] [Related]  

  • 10. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.
    Bonhomme J; Shim RS; Gooden R; Tyus D; Rust G
    J Natl Med Assoc; 2012; 104(7-8):342-50. PubMed ID: 23092049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid dependence.
    Benich JJ
    Prim Care; 2011 Mar; 38(1):59-70. PubMed ID: 21356421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.
    Saloner B; Stoller KB; Alexander GC
    N Engl J Med; 2018 Jul; 379(1):4-6. PubMed ID: 29972745
    [No Abstract]   [Full Text] [Related]  

  • 13. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using buprenorphine for outpatient opioid detoxification.
    Manlandro JJ
    J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES11-6. PubMed ID: 17908825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine: a review.
    Wakhlu S
    J Opioid Manag; 2009; 5(1):59-64. PubMed ID: 19344049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid dependence treatment: options in pharmacotherapy.
    Stotts AL; Dodrill CL; Kosten TR
    Expert Opin Pharmacother; 2009 Aug; 10(11):1727-40. PubMed ID: 19538000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agency offers guidance on office-based drug treatment for opioid addiction.
    Mitka M
    JAMA; 2003 Feb; 289(6):690. PubMed ID: 12585931
    [No Abstract]   [Full Text] [Related]  

  • 19. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 20. Buprenorphine-containing treatments: place in the management of opioid addiction.
    Robinson SE
    CNS Drugs; 2006; 20(9):697-712. PubMed ID: 16953647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.